Canada markets closed

Vanda Pharmaceuticals Inc. (VNDA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
5.48-0.10 (-1.79%)
At close: 04:00PM EDT
5.60 +0.12 (+2.18%)
After hours: 07:49PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 318.93M
Enterprise Value -66.29M
Trailing P/E 111.25
Forward P/E 30.30
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.78
Price/Book (mrq)0.59
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.71
52-Week Change 3-11.61%
S&P500 52-Week Change 326.49%
52 Week High 36.76
52 Week Low 33.30
50-Day Moving Average 34.50
200-Day Moving Average 34.39

Share Statistics

Avg Vol (3 month) 32.4M
Avg Vol (10 day) 31.58M
Shares Outstanding 558.2M
Implied Shares Outstanding 658.2M
Float 852.25M
% Held by Insiders 12.99%
% Held by Institutions 186.11%
Shares Short (Apr 30, 2024) 42.3M
Short Ratio (Apr 30, 2024) 40.47
Short % of Float (Apr 30, 2024) 44.79%
Short % of Shares Outstanding (Apr 30, 2024) 43.96%
Shares Short (prior month Mar 28, 2024) 42.49M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin -2.75%
Operating Margin (ttm)-19.46%

Management Effectiveness

Return on Assets (ttm)-2.43%
Return on Equity (ttm)-0.91%

Income Statement

Revenue (ttm)177.6M
Revenue Per Share (ttm)3.09
Quarterly Revenue Growth (yoy)-24.10%
Gross Profit (ttm)N/A
EBITDA -20.63M
Net Income Avi to Common (ttm)-4.89M
Diluted EPS (ttm)-0.09
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)394.14M
Total Cash Per Share (mrq)6.77
Total Debt (mrq)8.92M
Total Debt/Equity (mrq)1.64%
Current Ratio (mrq)4.71
Book Value Per Share (mrq)9.35

Cash Flow Statement

Operating Cash Flow (ttm)-11.43M
Levered Free Cash Flow (ttm)-115.2M